ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity
The atypical chemokine receptor ACKR2 regulates immune responses. Here the authors confirm that ACKR2 depletion promotes primary tumor growth but show it has an anti-metastatic effect in mouse models of breast cancer by affecting myeloid differentiation and unleashing the anti-metastatic activity of...
Saved in:
Main Authors: | Matteo Massara, Ornella Bonavita, Benedetta Savino, Nicoletta Caronni, Valeria Mollica Poeta, Marina Sironi, Elisa Setten, Camilla Recordati, Laura Crisafulli, Francesca Ficara, Alberto Mantovani, Massimo Locati, Raffaella Bonecchi |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/3c65e1c5ccf540638c6d891c8d6bd90e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides
by: Max Meyrath, et al.
Published: (2020) -
Checkpoints
by: Jean Arasanayagam
Published: (2016) -
Glutamine metabolism regulates endothelial to hematopoietic transition and hematopoietic lineage specification
by: Leal Oburoglu, et al.
Published: (2021) -
Hematopoietic stem cell transplantation
by: Eleftheria Hatzimichael, et al.
Published: (2010) -
Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
by: Shanshan Zhang, et al.
Published: (2021)